Several Wall Street analysts updated their ratings and price targets for Onto Innovation, with most maintaining 'buy' ratings but generally lowering price targets. This indicates a slightly less optimistic outlook on the stock's near-term valuation despite continued confidence in its long-term prospects.
On November 11, 2026, multiple Wall Street analysts issued updated research notes on Onto Innovation. While all four analysts maintained their 'buy' ratings, three of the four significantly lowered their price targets, with Evercore's Vedvati Shrotre making the most substantial cut from $390 to $250. This collective downward revision in price targets, despite maintained buy ratings, suggests a recalibration of valuation expectations for ONTO. For traders, this could signal short-term downward pressure on the stock as the market digests these revised outlooks, even if the long-term bullish sentiment remains. The key risk is that the market focuses more on the reduced price targets than the maintained buy ratings, potentially leading to a temporary dip.